Castorena-Maldonado A, Ramírez-García A, Carranco-Hernández L, Pérez-Delgadillo G, Toledo-Varela M

Language: Spanish
References: 12
Page: 52-61
PDF size: 338.58 Kb.

ABSTRACT

Objectives:To determine the state distribution of hearing disability in Mexico and to describe the state of the neonatal hearing screening.
Materials and Methods: A retrospective and cross-sectional study using databases of discharge diagnoses from the Ministry of Health of Mexico, national births and the geostatistical framework of INEGI to build cartographic maps. The hearing disability variable was constructed in accordance with the ICD-10 codes of the main condition, establishing the denominator for the calculation of specific rates. The georeference was made with the choropleth method, autoregressive analysis, post-estimation of Moran.
Results: The hearing disability rate was of 25.2 (95% CI 19.4-31.7) for every 10,000 patients seen in the Ministry of Health from January to December 2019, being the highest in Aguascalientes and the lowest in the Estado of Mexico; 59% of the cases corresponded to children younger than one year followed by 14.3% of patients between 18 to 64 years. Viral infections were the ones that most had a spatial distribution (W = 0.00). The hearing disability rate was of 1.55 (CI95% 1.19-1.91) per 10,000 births.
Conclusions: Hearing disability had a geospatial dependence that could have an origin of contiguity. This information has public health implications.

REFERENCES

1. https://www.who.int/es/news-room/fact-sheets/detail/ deafness-and-hearing-loss.

2. Instituto Nacional de Estadística y Geografía (México). La discapacidad en México, datos al 2014: versión 2017/ Instituto Nacional de Estadística y Geografía. México: INEGI, c2017.

3. Sharma A, Dorman MF, Spahr AJ. A sensitive period for the development of the central auditory system in children with cochlear implants: implications for age of implantation. Ear Hear 2002; 23 (6): 532-9. doi: 10.1097/00003446- 200212000-00004.

4. Lantos PM, Hoffman K, Permar SR, Jackson P, Hughes BL, Swamy GK. Geographic disparities in cytomegalovirus infection during pregnancy. J Pediatric Infect Dis Soc 2017; 6 (3): e55-e61. doi: 10.1093/jpids/piw088.

5. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390 (10100): 1211-1259. doi: 10.1016/S0140-6736(17)32154-2.

6. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396 (10258): 1204-1222. doi: 10.1016/S0140-6736(20)30925-9.

7. https://www.inegi.org.mx/temas/mg/.

8. https://www.gob.mx/salud/acciones-y-programas/ direccion-general-de-informacion-en-salud-dgis.

9. Graue-Hernández EO, Gómez-Dantés H, Romero-Martínez M, Bravo G, Arrieta-Camacho J, Jiménez-Corona A. Autorreporte de pérdida auditiva y discapacidad visual en adultos del centro de México [Self-reported hearing loss and visual impairment in adults from Central Mexico]. Salud Publica Mex 2019; 61 (5): 629-636.

10. The World Health Organization. Elimination of motherto- child transmission (EMTCT) of HIV and syphilis: Global guidance on criteria and processes for validation. http://www.who.int/reproductivehealth/publications/ rtis/9789241505888/en/.

11. Yee-Arellano HM, Leal-Garza F, Pauli-Müller K. Universal newborn hearing screening in Mexico: results of the first 2 years. Int J Pediatr Otorhinolaryngol 2006; 70 (11): 1863- 70. doi: 10.1016/j.ijporl.2006.06.008.

12. Ryan MA, Olshan AF, Canfield MA, Hoyt AT, et al. Sociodemographic, health behavioral, and clinical risk factors for anotia/microtia in a population-based case-control study. Int J Pediatr Otorhinolaryngol 2019; 122: 18-26. doi:10.1016/j.ijporl.2019.03.026.